Male breast cancer is a rare disease, of which little is known. In contrast to female breast
cancer, the very vast majority of all cases are positive for estrogen receptor alpha (ERα) …

The overexpression of the c-erbB-2 oncoprotein is now thought by most authors to be
associated with adverse prognosis in breast carcinoma. In this study, we investigate the …

We studied c-erbB-2, p53, and nm23 gene products in 112 primary breast carcinomas. Fifty
patients were aged 35 years or younger, and 62 were aged 36 to 50. Clinicopathological …

The aim of this study was to identify molecules involved in the proliferation and survival of
recurrent estrogen receptor (ER)-positive breast cancer at the site of metastasis. Most …

Background The association between p53 and c-erbB-2 overexpression relation to ER
status in ductal breast carcinoma is still unclear. Our aim was investigate the prognostic …

To elucidate the molecular profile of hormonal steroid receptor status, we analyzed ER-α,
ER-β, and PGR mRNA and protein expression in 80 breast carcinomas using reverse …

Abstract c‐erbB‐2 and ras expression was measured on tumor extracts from 132 human
primary breast carcinomas, by immunoblotting analysis. Expression of the c‐erbB‐2 …

Several oncogenes and tumour-suppressor genes have been identified that may have an
important role in the development of human breast carcinoma. Furthermore, some of these …

The role of estrogen (ER) and progesterone receptors (PR) in breast cancer is well
established. Identification of the second human estrogen receptor, the estrogen receptor β …

Aim: The biological impact of cell cycle regulatory proteins on breast cancer progression is
widely recognised, although mostly unclear. The aim of this preliminary study was to …